Eli Lilly is spending $3.25 billion to acquire Kelonia Therapeutics, a small biotech company developing cell therapies for cancer and autoimmune diseases, the companies announced Monday. Lilly coul… [+1022 chars]Read More
Eli Lillys 325 billion acquisition of Kelonia Therapeutics caps startups tortuous ride statnewscom
